To investigate whether the cardioprotective effect of SGLT2 inhibition on HF was mediated by acylcarnitines, we performed a drug-target MR analysis to assess the causal effect of SGLT2 inhibition on circulating acylcarnitines and further examined the association between acylcarnitines and incident HF. This evidence concerns the gene SLC5A2 and hydrops fetalis.